Rhumbline Advisers lifted its holdings in National Health Investors, Inc. (NYSE:NHI – Free Report) by 1.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,309 shares of the real estate investment trust’s stock after buying an additional 1,226 shares during the quarter. Rhumbline Advisers owned approximately 0.17% of National Health Investors worth $5,496,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in NHI. Jane Street Group LLC grew its position in National Health Investors by 68.3% in the 3rd quarter. Jane Street Group LLC now owns 60,099 shares of the real estate investment trust’s stock worth $5,052,000 after purchasing an additional 24,380 shares during the period. Thrivent Financial for Lutherans purchased a new stake in National Health Investors during the third quarter valued at $2,426,000. Point72 Asset Management L.P. bought a new position in National Health Investors in the third quarter valued at about $688,000. Charles Schwab Investment Management Inc. boosted its position in National Health Investors by 17.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust’s stock worth $71,651,000 after purchasing an additional 123,596 shares during the last quarter. Finally, Intech Investment Management LLC bought a new stake in shares of National Health Investors during the 3rd quarter valued at about $720,000. Institutional investors own 62.51% of the company’s stock.
Analysts Set New Price Targets
Separately, Truist Financial dropped their price objective on shares of National Health Investors from $78.00 to $72.00 and set a “hold” rating on the stock in a report on Monday, December 23rd. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $76.60.
National Health Investors Price Performance
NHI stock opened at $71.24 on Friday. The stock has a market cap of $3.24 billion, a PE ratio of 24.48, a P/E/G ratio of 4.42 and a beta of 1.06. The company has a 50-day moving average price of $68.69 and a 200 day moving average price of $75.03. National Health Investors, Inc. has a 12 month low of $56.70 and a 12 month high of $86.13. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92.
National Health Investors (NYSE:NHI – Get Free Report) last issued its earnings results on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.03. The business had revenue of $85.75 million during the quarter, compared to analysts’ expectations of $81.13 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. Equities research analysts anticipate that National Health Investors, Inc. will post 4.41 earnings per share for the current year.
National Health Investors Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 2nd. Stockholders of record on Monday, March 31st will be issued a dividend of $0.90 per share. The ex-dividend date is Monday, March 31st. This represents a $3.60 annualized dividend and a dividend yield of 5.05%. National Health Investors’s dividend payout ratio is presently 123.71%.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
- Five stocks we like better than National Health Investors
- How to Plot Fibonacci Price Inflection Levels
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Retail Stocks Investing, Explained
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.